Regular, Long-Term Physical Activity Tied to Better Sleep Outcomes
By Lori Solomon HealthDay Reporter
THURSDAY, March 28, 2024 -- Physically active people have a lower risk for some poor sleep outcomes, according to a study published online March 26 in BMJ Open.
Erla Bjornsdottir, Ph.D., from Reykjavik University in Iceland, and colleagues explored the relationship between physical activity during a 10-year period and current symptoms of insomnia, daytime sleepiness, and estimated sleep duration. The analysis included 4,339 adults (aged 39 to 67 years) participating in the European Community Respiratory Health Survey.
The researchers found that during follow-up, 37 percent of participants were persistently nonactive, 25 percent were persistently active, 20 percent became inactive, and 18 percent became active. Difficulties initiating sleep were less likely to be reported by participants who were persistently active versus those who were persistently nonactive (odds ratio, 0.60), as was a short sleep duration of no more than six hours/night (odds ratio, 0.71) and a long sleep duration of at least nine hours/night (odds ratio, 0.53), when adjusting for age, sex, body mass index, smoking history, and study center. There were no associations between daytime sleepiness or difficulties maintaining sleep and physical activity status.
"Our results are in line with previous studies that have shown the beneficial effect of physical activity on symptoms of insomnia, but the current study additionally shows the importance of consistency in exercising over time, because the association was lost for initially active subjects who became inactive," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.